Considering that Mcl-1 may contribute to decrease venetoclax-induced apoptosis (26), we aimed to determine the sensitivity of CLL cells to venetoclax treatment, comparing the response of CLL cells isolated from patients harboring trisomy 12 to no trisomy 12. The gene discussed is MCL1; the disease is B-cell chronic lymphocytic leukemia.